Cite
Higuchi A, Oshima T, Yoshihara K, et al. Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy. Oncol Lett. 2016;13(2):905-911doi: 10.3892/ol.2016.5494.
Higuchi, A., Oshima, T., Yoshihara, K., Sakamaki, K., Aoyama, T., Suganuma, N., Yamamoto, N., Sato, T., Cho, H., Shiozawa, M., Yoshikawa, T., Rino, Y., Kunisaki, C., Imada, T., & Masuda, M. (2017). Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy. Oncology letters, 13(2), 905-911. https://doi.org/10.3892/ol.2016.5494
Higuchi, Akio, et al. "Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy." Oncology letters vol. 13,2 (2017): 905-911. doi: https://doi.org/10.3892/ol.2016.5494
Higuchi A, Oshima T, Yoshihara K, Sakamaki K, Aoyama T, Suganuma N, Yamamoto N, Sato T, Cho H, Shiozawa M, Yoshikawa T, Rino Y, Kunisaki C, Imada T, Masuda M. Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy. Oncol Lett. 2017 Feb;13(2):905-911. doi: 10.3892/ol.2016.5494. Epub 2016 Dec 14. PMID: 28356977; PMCID: PMC5351282.
Copy
Download .nbib